January is Substance Use Disorder Treatment Month, which is designed to raise awareness about those suffering with substance ...

TikTok, Instagram, YouTube and computer games pose a more immediate threat to teens than alcohol and cannabis, according to new research in Germany, shedding light on the numbers of teens with ...

While Baseline Therapeutics declined to disclose its starting capital, the startup said it will use the funds to push its GLP-1 asset BT-001 into late-stage development, with two trials planned this ...

Aiming to address the connections between addiction and mental health disorders, the Partnership for a Drug-Free New Jersey recently hosted a webinar to discuss the best ways to treat both together.

Anyone with addiction has complex issues with short- and long-term needs. Almost 40% of patients with SUD/AUD have ...

A new doctoral dissertation shows that gambling disorder is linked to brain networks involved in self-control and brain ...

Ozempic was first approved to treat type 2 diabetes in 2017, but it’s garnered most of its recognition in recent years as a weight-loss drug. Now, as more people are taking it and scientists are ...

Ozempic and similar semaglutide-based medications have been hailed as miracle drugs. Known as GLP-1 (glucagon-like peptide-1) agonists, this class of medications mimics a natural hormone the small ...

Please provide your email address to receive an email when new articles are posted on . Data GLP-1s may have benefits beyond glycemic control, weight loss and CVD prevention. Alzheimer's disease, ...

"In this multicentre tertiary care study across 20 European countries, addictive disorders were common among patients with chronic skin diseases," the authors wrote, adding that "the observed ...